BioWorld Asia

Jan. 9, 2002

View Archived Issues

PPL Clones Knockout Pigs, Says Dolly’s Arthritis Not A Setback

New Heart Drugs Could Be Hiding In A Glass Of Vin Rouge

NeuTec Raising 10M To Fund Programs Targeting Infections

Budget Cuts Sidetrack Plan For Israeli Biotech Institute

Antisoma, Abbott Restructure Deal Regarding Cancer Drug

Novartis Enlists Optimata To Analyze New Drug Candidates

Strakan Raises Another £15M, Gains UK Approval For Zindaclin

ExonHit Partners With IDEC To Develop Antibody Therapeutics

PARIS - ExonHit Therapeutics SA and IDEC Pharmaceuticals Corp. signed a collaboration and research agreement aimed at discovering new antigen targets for antibody therapy, with a particular focus on prostate carcinoma. Read More

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for July 6, 2026.

CINP 2026: Prenatal and adolescent stress shape brain vulnerability

BioWorld Science

Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...

Ontrack Therapeutics divulges compounds for neurodegenerative diseases

BioWorld Science

Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.

Neuracle eyes Shanghai IPO as global BCI funding surges

BioWorld

Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...

Modius Spero wearable neuromodulation device

Neurovalens granted FDA approval for PTSD therapy for US veterans

BioWorld

Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...